Assertio Therapeutics, Inc.
Angona rejisitra ofisialy
0mpanaraka
2018naorina
Momba an'i Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Foiben-toerana251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Naorina2018
SataMiasa
Patanty1 patanty
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Hevitra
Tsy mbola misy hevitra. Niara-niasa tamin'i Assertio Therapeutics, Inc.? Ho voalohany mizara ny traikefanao.
Fampahalalana ara-dalàna
| Anarana ara-dalàna | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Hijery ao amin'ny GLEIF ↗ |
| Adiresy voasoratra | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Sata | Miasa |
Loharano: GLEIF · nohavaozina Oct. 16, 2026
Fifandraisana sy rohy
Toerana
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Ny orinasanao ve ity?
Takio ity pejy ity maimaim-poana hampiana ny famantarana, ny vokatra, ny sary ary ny asa, ary hamaliana hevitra.
Takio ity pejy ityMidira ao amin'i Heelky hifandray, hanakarama ary hitombo
Mamorona kaonty maimaim-poana handefasana hafatra, hangataka asa ary hamoahana iraka.
Midira izao — maimaim-poana